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Background: The eight Performance Scales and three assimilated scales (PS) used in North American Research
Committee on Multiple Sclerosis (NARCOMS) registry surveys cover a broad range of neurologic domains commonly
affected by multiple sclerosis (mobility, hand function, vision, fatigue, cognition, bladder/bowel, sensory, spasticity, pain,
depression, and tremor/coordination). Each scale consists of a single 6-to-7-point Likert item with response categories
ranging from “normal” to “total disability”. Relatively little is known about the performances of the summary index of
disability derived from these scales (the Performance Scales Sum or PSS). In this study, we demonstrate the value of a
combination of classical and modern methods recently proposed by the Patient-Reported Outcome Measurement
Information System (PROMIS) network to evaluate the psychometric properties of the PSS and derive an improved
measure of global disability from the PS.
Methods: The study sample included 7,851adults with MS who completed a NARCOMS intake questionnaire between
2003 and 2011. Factor analysis, bifactor modeling, and item response theory (IRT) analysis were used to evaluate the
dimension(s) of disability underlying the PS; calibrate the 11 scales; and generate three alternative summary scores of
global disability corresponding to different model assumptions and practical priorities. The construct validity of the
three scores was compared by examining the magnitude of their associations with participant’s background
characteristics, including unemployment.
Results: We derived structurally valid measures of global disability from the PS through the proposed methodology
that were superior to the PSS. The measure most applicable to clinical practice gives similar weight to physical and
mental disability. Overall reliability of the new measure is acceptable for individual comparisons (0.87). Higher scores of
global disability were significantly associated with older age at assessment, longer disease duration, male gender,
Native-American ethnicity, not receiving disease modifying therapy, unemployment, and higher scores on the Patient
Determined Disease Steps (PDDS).
Conclusion: Promising, interpretable and easily-obtainable IRT scores of global disability were generated from the PS
by using a sequence of traditional and modern psychometric methods based on PROMIS recommendations. Our
analyses shed new light on the construct of global disability in MS.
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There is an acute need for a reliable and valid quantita-
tive outcome measure of “global disability” in multiple
sclerosis (MS) from the patient’s perspective. The North
American Research Committee on Multiple Sclerosis
(NARCOMS) registry, a volunteer registry that repre-
sents approximately 10% of the U.S. MS population
affords a unique opportunity to develop and validate
such a measure. Since 1998, the NARCOMS registry has
employed the Performances Scales (PS) to assess per-
ceived disability in adults living with MS [1]. Single-item
PS were originally developed for eight domains of func-
tion (mobility, hand function, vision, fatigue, cognition,
bladder/bowel, sensory, and spasticity) [1]. To increase
content validity [2,3], three more measures were added
in 2001 to assess disability associated with pain [4],
depression [5], and tremor/coordination [6]. Responses
are recorded on a 6-point ordinal scale (0 normal, 1
minimal, 2 mild, 3 moderate, 4 severe, and 5 total
disability) except for the mobility PS which is scored
from 0 to 6.
The measurement properties of each individual PS are
generally excellent. Non-response rates are low (1%-5%)
and test-retest reliability high (median, 0.82, range 0.65-
0.91) [1]. Evidence of criterion and construct validity is
strong for virtually all the scales (Additional file 1) [4-9].
Although the PS have generally been analyzed separately,
several authors have added raw scores on the eight ori-
ginal PS to form an ordinal summary index of disability,
referred to as Performance Scales Sum (PSS-8) [1,7,10-12].
The PSS-8, has shown favorable properties in terms
of internal consistency (Cronbach’s alpha, 0.78), test-retest
reliability (intraclass coefficient of correlation, 0.89), and
criterion validity (correlation with EDDS, 0.62-0.64; correl-
ation with MSFC, 0.58) [1,7]. Growing evidence also sup-
ports its discriminant and incremental validity [1,10].
Furthermore only minimal response shift has been de-
tected when administering the PS repetitively over a 1-
year period [11].
An important unresolved question about the PS is that
of whether a single sum score, such as the PSS-8, ad-
equately reflects underlying global disability or whether
two or more summary scores are needed to validly capture
information on disability domains assessed by the PS. For
instance, recent factor analysis of 7 of the original 8 PS
(vision scale excluded, PSS-7) suggested that a better rep-
resentation of a patient’s disability might be obtained with
two separate scores─one combining the mobility, spasti-
city and bladder/bowel PS, and the other combining the
hand function, fatigue, sensory, and cognition PS [11].
We and others have described how categorical factor
analysis and bifactor analysis could help uncover the fine
structure of disability in MS [13,14]. In this article, we
apply these methods and related techniques put forwardby the Patient-Reported Outcome Measurement Infor-
mation System (PROMIS) network [15] to the evaluation
of the measurement structure of the 11 PS in a large
cross-sectional sample of NARCOMS registrants. We
explain how results from these analyses informed the
Item Response Theory (IRT) calibration of the PS on a
single scale of self-assessed global disability. Finally we
compare the construct validity of three summary scores
of global disability derived using assumptions and calcu-
lation methods of varying practicality and accuracy. To
appeal to a wide readership, methodological details are
presented in Additional file 2.
Methods
Study sample
Study data included NARCOMS recruitment surveys
collected in 2003–2011. Analyses were restricted to
participants who completed the pain, depression and
tremor PS, which were not consistently included in each
intake survey, and to patients who indicated whether or
not they had a confirmed diagnosis of MS. Disability
items consisted of the 11 PS and the Patient Determined
Disease Steps (PDDS)─a patient-assessed single-item
measure of perceived disability that correlates as high as
0.78 with the Expanded Disability Status Scale (EDSS)
[16]. Other variables available included calendar year of
survey completion, gender, race/ethnicity, age at first
symptoms, disease duration, employment status, whether
the respondent was on disease modifying therapy (DMT)
at enrollment, and year of MS diagnosis.
The total sample was randomly split into a development
sample (exploratory analyses) and a validation sample
(main analyses).
The NARCOMS Registry is approved by the Institu-
tional Review Board of the University of Alabama at
Birmingham.
Preliminary analyses
After performing traditional descriptive statistics for the
11 PS, we conducted exploratory factor analysis (EFA) in
the development sample to obtain initial information as
to whether the PS should be aggregated into one or
more than one disability measures (Additional file 2)
[17,18]. Then, based on EFA results and the literature
[19], we used confirmatory factor analysis (CFA) to test
the fit of the most promising models to the data of the
validation sample (Additional file 2).
Item calibration and measurement
Although IRT and CFA models belong to the same
family of latent variable models, IRT models provide
more detailed information about the functioning of each
item. IRT methods also present several advantages for
rigorous scale development and score interpretation [20].
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lowing: examine whether respondents reliably distinguished
between adjacent PS categories (Additional file 2); cali-
brate the PS according to the assumptions of two
closely-related, and similarly plausible, CFA models; and
generate corresponding IRT-based scores of disability
(Additional file 2) [21]. To facilitate interpretation, all
IRT scores were transformed to have mean 50 and SD
15 so that >99% of scores in the NARCOMS sample
would range between 5 and 95.
Construct validity
Construct validity was assessed using known-group com-
parisons, that is, analysis was performed to compare the
means of IRT scores generated in the previous step across
the categories of key patient characteristics including
PDDS score, age, gender, race/ethnicity, disease duration,
and year of assessment. We also assessed the associations
of IRT score estimates with unemployment, controlling
for other potential predictors of unemployment. We used
Mplus 6.1 for general psychometric analyses, IRTPRO 2.1
for IRT calibration and IRT scale score estimation, and
Stata 12.1 for the other analyses.
Results
Of the 12,563 persons who filled a NARCOMS intake
questionnaire between 2003 and 2011, 7,851registrants
with self-reported diagnosis of MS completed all 11 PS.
Nearly 80% of participants were women; 93% were
white, and 53% completed their intake questionnaire in
2007 or later. Mean age was 46 years (SD, 11.1); mean
age at diagnosis 39 years (SD, 10), and mean disease dur-
ation 15 years (SD, 11.3). Two-third of respondents were
on disease-modifying therapy; 51% were unemployed.
Except if stated otherwise, all the results below were ob-
tained from the validation sample after revision of PS re-
sponse options as described in Additional file 2 (i.e., after a
first round of analysis indicated that response options
should be reduced from 7 to 6 for the mobility PS and
from 6 to 5 for all the other PS except the fatigue PS).
PSS-11 scores, (i.e., traditional raw summed scores) ranged
from 0 to 43 out of a revised maximum total of 46.
Preliminary analyses
EFA suggested that one or two factors (i.e., underlying
dimensions of disability) might satisfactorily explain
covariations among PS (Additional file 2) [22]. As a
follow-up, we fitted three CFA models to the data
(Additional file 2): (1) a unidimensional model, where
the 11 PS represented a single construct of global dis-
ability; (2) a two-dimensional model composed of two
correlated factors that we loosely referred to as “physical
disability” (mobility, hand, bladder/bowel, spasticity and
tremor PS) and “mental disability” (cognition, fatigue,pain, sensory, depression, vision PS); and (3) a hybrid
bifactor model [18,23], where the variability common to
all 11 PS was captured by a general factor of global
disability, and residual fractions of PS variability not
accounted for by the general factor were captured by
two auxiliary factors of “physical” and “mental” disability.
In this latter model, a strong general factor and weak aux-
iliary factors would suggest that the structure of the data
is “almost” unidimensional, and therefore that Model 1
might be preferred over Model 2 (we refer the readers to
our article [14] for a general discussion of Models 1–3).
The unidimensional model had a mediocre fit, but the
PS-factor correlations were all moderate to large (mean,
0.65; range, 0.50-0.77; Figure 1).
The fit of the two-dimensional model was only mar-
ginally better than that of the unidimensional model. In-
dividual PS correlated 0.52-to-0.80 with their respective
factor (means, 0.69 for the physical disability factor and
0.67 for the mental disability factor). Correlation be-
tween the two factors was high (0.83). Misfit was pri-
marily due to the sensory PS substantially contributing
to both the physical factor and the mental factor.
The bifactor CFA model was specified so that the
sensory PS contributed only to the general factor (i.e., to
what the physical and mental PS measured in common;
Figure 2). The fit of this model was excellent. Correla-
tions between the PS and the factor of global disability
were very similar to their counterpart in the unidi-
mensional model. The largest differences in factor-PS
correlations were observed for the mobility PS (correl-
ation of 0.55 in the bifactor model vs. 0.66 in the unidi-
mensional model) and the cognition PS (correlation of
0.56 in the bifactor model vs. 0.65 in the unidimensional
model) . Both differences matched the accepted standard
of ≤0.15 for a small difference [24]. This suggested that
the mobility and cognitive PS would be only slightly
overrepresented in scores of global disability obtained
from the parsimonious, unidimensional, IRT model
compared to scores of global disability obtained from
the more complex bifactor IRT model. Furthermore, the
variance of PS sum scores was decomposed into a large
fraction explained by the factor of global disability
(79%), a small fraction explained by the two auxiliary
factors (11%), and a small fraction of residual error (10%)
[25]. Expressed differently, 87.8% of reliable variance in
the sum score represented global disability as opposed to
domain-specific disability. This result was in line with the
finding that only two PS had salient correlations with the
factor of residual physical disability (mobility, 0.81 and
tremor/coordination, 0.33) and three with the factor of
residual mental disability (cognition, 0.56; depression,
0.39; and vision, 0.32). Since the auxiliary factors of a
bifactor model are considered to be minor and ill-defined







































Figure 1 Unidimensional CFA model of self-assessed neurological disability in NARCOMS registrants. Note: “Disability” represents a latent
factor, i.e., a not directly observable continuous variable whose scale is inferred from the variability and correlations among PS. “PS-factor correlations”
are estimates of the correlations between PS and factor scores. “Residual variances” represent the fractions of PS score variability that are not explained
by the factor.
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residual physical and mental disability might not be esti-
mated with sufficient accuracy to be of practical import-
ance in less than very large studies.
IRT calibration and measurement
We fitted both a unidimensional- and a bifactor IRT
model to the data. The bifactor IRT model replicated the
measurement structure of the bifactor CFA model.
The fit of both models was acceptable (Additional
file 2), but neither supported the validity of a raw summed
score such as the PSS-11 [27]. IRT models indicated in
particular that the level of disability corresponding to a
given PSS-11 summed score varied as a function of the
pattern of responses to PS items. This is illustrated in
Figure 3 which describes the relations between IRT scale
of global disability from the unidimensional model, raw
PSS-11 scores, and standing of PS categories on the IRT
scale. The figure, for instance, indicates that a minimum
level of fatigue disability contributed less to global disability
on the IRT scale than a minimum level of mobility disabil-
ity. The figure also shows that the distance between two
consecutive raw PSS-11 scores varied along the IRT scalecontinuum. In this situation IRT modeling offered two op-
tions. The simplest, but more approximate option was to
directly convert raw PSS-11 scores into IRT summed scores
by aligning the former on the more linear IRT scale. The
more rigorous, but less practical option was to estimate
IRT pattern scores that account for the fact that combina-
tions of PS responses corresponding to distinct true levels
of disability may yield the same raw summed score [28,29].
For each PSS raw summed score, one IRT summed score
would be generated versus several IRT pattern scores. IRT
summed scores would maintain the simplicity of PSS-11
scores, but at the cost of some loss of accuracy. Pattern
scores would be more accurate, but too cumbersome to
be calculated without a computer application.
To examine the trade-offs among the most promising
alternatives, we calculated IRT summed scores and IRT
pattern scores of global disability from the unidimensional
model, and IRT pattern scores of global disability, residual
physical disability, and residual mental disability from the
bifactor model. Unless stated otherwise, in what follows
“summed scores” and “pattern scores” will refer to IRT
scores generated from the unidimensional model, and “bifac-





















































Figure 2 Bifactor CFA model of self-assessed neurological disability in NARCOMS registrants. Note: “Global” represents the general factor
of global disability; “Physical” and “Mental” represent the auxiliary factors of “physical” and “mental” disability. Correlations among the three factors
are all forced to be zero. Thus, the physical and mental factors each explain a fraction of the variability in PS scores left unexplained by the general
factor. Comparisons of “Residual variances” in Figure 2 and Figure 1, provide information about the fraction of variability in PS scores that the two
auxiliary factors explain above and beyond the general factor.
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to corresponding IRT summed score levels provided fur-
ther evidence of the shortcomings of the PSS-11 summed
scale─low raw PSS-11 scores (0-to-15) were shown to
underestimate corresponding IRT summed scores, while
high raw PSS-11 scores (21-to-46) overestimated them.
(Figure 4). Therefore, in Additional file 3, we provide a
conversion table that appropriately translates raw PSS-11
scores into IRT summed scores of global disability [28,29].
In contrast, differences between IRT summed and IRT
pattern scores of global disability were generally small
(mean, −0.07; SD, 2.1) and so were differences between
pattern scores and bifactor scores of global disability
(mean, 0.0; SD, 2.3). In both cases differences were near
zero in the 20-to-80 IRT-score range. These results
suggested that the IRT summed score approximation was
unlikely to lead to clinically-relevant measurement bias.Overall reliability of the IRT summed scores of global
disability was 0.87.
Construct validity
We observed positive and statistically significant associa-
tions between mean IRT scores of global disability and
PDDS scores (P < 0.001; Figure 5A). Increases in IRT
scores of global disability were sharper over the lower
portion of the PDSS scale (0-to-2) than over its higher
portion (3-to-8). Differences between summed-, pattern-
, and bifactor score estimates of global disability were
generally minimal (standardized differences <0.15 except
for PDDS 7). Mean bifactor scores of residual physical
disability increased significantly and nearly linearly with
increasing PDSS scores (P < 0.001; Figure 5B). In con-
trast, mean bifactor scores of residual mental disability
increased significantly over PDSS scores 0-to-2 and then
Figure 3 Relation among Performance Scale (PS) categories, Performance Scales Sum (PSS-11) scores and PS IRT scores of global
disability (from unidimensional model) in a sample of NARCOMS registrants.
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sistent with the higher portion of the PDDS scale being
biased toward physical disability. Alternatively, these pat-
terns may also indicate that patients experiencing high
levels of “mental” disability were less likely to enroll in
NARCOMS.
In bivariable analysis, higher IRT scores of global disabil-
ity were significantly and consistently associated with lon-
ger disease duration, older age at assessment, male gender,
Native American ethnicity, not receiving DMT, and in-
take survey completed in 2003–2005 and 2009–2011,Figure 4 Relations among the levels of the Performance Scales Sum (PS
facilitate comparisons, the levels of the IRT summed score were linearly transf
had the levels of the two scores been perfectly equivalent, then the dots on tcompared to 2006–2008 (Table 1). Differences accord-
ing to the type of score estimate (summed, pattern,
bifactor) were small compared to the widths of the con-
fidence intervals for the mean estimates. The pattern of
associations between personal characteristics and bifac-
tor scores of residual physical disability (respectively re-
sidual mental disability) closely paralleled that between
personal characteristics and IRT scores of global disabil-
ity. This latter result reinforced the hypothesis that the
11 PS were all indicators of one broad underlying con-
struct of global disability.S-11) score and the IRT summed score of global disability. Note: To
ormed to range from 0 to 46 (i.e., the range of the PSS-11 levels). Thus,
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Figure 5 Associations between Performance Scales-based, IRT-derived, scores of disability and PDDS scores in a sample of NARCOMS
registrants. a) Scores of global disability generated from the bifactor IRT model (●) versus the unidimensional IRT model (□, pattern scores;▲,
summed scores). b) Scores of residual physical disability generated from the bifactor IRT model. c) Scores of residual mental disability generated from
the bifactor IRT model. Note: Although the scores of global disability, residual physical disability, and residual mental disability are all reported as scaled
scores (Mean, 50; SD, 15), they are not on the same metric. Error bars represent 95% confidence intervals. Spearman correlations between IRT scores
and PDDS scores: Figure 5a) ● 0.60, □ 0.65,▲0.68; Figure 5b) 0.72; Figure 5c) 0.07.
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Table 1 Performance Scales-based, IRT-derived, scaled scores of disability by patient characteristics




Bifactor Unidimensional Unidimensional Bifactor Bifactor
Patterna (95% CI) Patterna (95% CI) Summedb (95% CI) Patterna (95% CI) Patterna (95% CI)
Age at assessment (y.)
≤ 35 749 (19.1) 45.2 (44.1, 46.2)*** 44.6 (43.6, 45.7)*** 44.5 (43.5, 45.6)*** 42.5 (41.7, 43.4)*** 41.2 (40.2, 42.2)***
36 – 55 1760 (44.8) 50.3 (49.6, 51.0) 50.1 (49.4, 50.8) 50.0. (49.3, 50.7) 47.8 (47.1, 48.4) 47.4 (46.6, 48.2)
≥ 56 1417 (36.1) 52.2 (51.5, 53.0) 52.7 (52.0, 53.5) 52.9 (52.2, 53.7) 56.7 (55.9, 57.5) 57.9. (57.0, 58.8)
Disease duration (y.)
≤ 10 1713 (43.6) 46.2 (45.5, 46.9)*** 45.7 (45.0, 46.5)*** 45.5 (44.8, 46.2)*** 45.2 (44.5, 45.8)*** 44.3 (43.6, 45.0)***
11 – 20 1109 (28.3) 51.7 (50.9, 52.6) 51.8 (51.0, 52.7) 51.9 (51.1, 52.7) 50.6 (49.7, 51.5) 50.7 (49.7, 51.7)
≥ 21 1104 (28.1) 54.2 (53.3, 55.0) 54.8 (54.0, 55.6) 55.1 (54.3, 55.9) 56.9 (56.0, 57.8) 58.2 (57.1, 59.2)
Gender
Female 3102 (79.4) 49.7 (49.2, 50.2)** 49.6 (49.1, 50.1)*** 49.5 (49.0, 50.0)*** 48.8 (48.3, 49.3)*** 48.5. (47.9, 49.1)***
Male 803 (20.6) 51.3 (50.2 52.4) 51.6 (50.5, 52.7) 51.9 (50.8, 53.0) 54.8 (53.7, 55.9) 55.6 (54.4, 56.9)
Race/Ethnicity
White 3491 (90.2) 49.8 (49.3, 50.3)*** 49.8 (49.3, 50.3)*** 49.7 (49.3, 50.2)*** 50.0 (49.5, 50.5)* 50.0 (49.4, 50.6)*
African American 132 (3.4) 50.7 (48.2, 53,2) 51.0 (48.6, 53.4) 51.5 (49.0, 54.0) 51.8 (49.0, 54.5) 52.1 (48.9, 55.3)
Hispanic/Latino 120 (3.1) 48.1. (45.2, 51.0) 47.9 (45.0, 50.8) 47.8 (44.8, 50.5) 46.5 (43.8, 49.2) 45.9. (42.7, 49.1)
Native American 76 (2.0) 56.7 (53.3, 60.1) 56.6 (53.2, 59.9) 56.7 (53.3, 60.1) 48.3 (45.6, 51.1) 48.0 (44.8, 51.3)
Other 49 (1.3) 53.4 (48.5, 58.1) 53.1 (48.3, 57.9) 53.3 (48.4, 58.3) 47.3. (43.6, 51.0) 46.8. (42.4, 51.2)
Disease modifying therapy
Yes 2614 (66.6) 49.2. (48.6, 49.8)*** 49.2 (48.6, 49.7)*** 49.1 (48.5, 49.7)*** 48.8. (48.2, 49.3)*** 48.6 (47.0, 49.2)***
No 1312 (33.4) 51.6 (50.8, 52.4) 51.7 (50.8, 52.5) 51.8 (51.0, 52.7) 52.4 (51.5, 53.3) 55.6 (54.4, 56.9)
Year of assessment
2003-2005 1640 (41.8) 50.0 (49.2, 50.7)** 50.3 (49.5, 51.0)* 50.6 (49.8, 51.3)* 51.1 (50.4, 51.9)*** 51.3 (50.4, 52.2)***
2006-2008 957 (24.4) 48.9 (47.9, 49.8) 49.0 (48.0, 49.9) 49.0 (48.1, 50.0) 49.1 (48.1, 50.0) 48.9 (47.7, 50.0)
2009-2011 1329 (33.8) 50.8 (50.0, 51.6) 50.4 (49.6, 51.2) 50.0 (49.2, 50.8) 49.3 (48.5, 50.1) 49.2 (48.3, 50.1)
aPattern stands for Bayesian Expected a Posteriori (EAP) score; as many different score estimates were produced for each raw PSS score as the number of item
response combinations yielding the PSS score.
bSummed stands for EAP Summed Score; only one summary EAP Summed Score was generated for each raw PSS score.
*P < 0.05; **P < 0.01; ***P < 0.001.
Note. The scores of global disability, residual physical disability, and residual mental disability are all reported as scaled scores (S) with mean 50 and SD 15, but
they are not on the same metric. All the scores of global disability are directly comparable, but not the scores of residual physical disability and residual mental
disability. For instance, because the SD of the score of global disability is much larger than that of the scores of physical and mental disability, a score of global
disability of S = 70 represents much more disability than a score of residual physical, or mental, disability of S = 70.
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distributions of IRT summed scores of global disability
among employed and unemployed respondents to the
estimated standing of raw PSS-11 scores on the IRT scale
of global disability. After adjustment for patient character-
istics, prevalence of unemployment among respondents
independently increased with increasing scores on all
three disability measures estimated from the bifactor
model (Table 2). Similarly, we also found dose–response
relationships between prevalence of unemployment and
summed-, and pattern scores of global disability. Pattern
scores of global disability were more strongly associated
with unemployment than bifactor scores of global disabil-
ity, presumably because pattern scores of global disabilityare a form of weighted average of the three bifactor scores
of disability (i.e., global-, residual physical-, and residual
mental-), and these three scores were all independently
associated with unemployment. After controlling for dis-
ability scores, prevalence ratio estimates for the personal
characteristic variables were remarkably similar across the
three regression models, once again suggesting that, des-
pite their imperfections, scores of global disability from
the unidimensional model captured most of the disability
variance explained by the bifactor model.
Discussion
This study supports the notion that information on



































































Figure 6 Relations between distributions of Performance Scales IRT scores (left) and raw Performance Scales Sum (PSS-11) scores
(right) among employed and unemployed NARCOMS registrants. Note: Data on causes of unemployment were not available.
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several limitations of the standard PSS-11 score were
uncovered in this role in terms of excessive number of
response categories for 10 items (Additional file 2),
underestimation of global disability in the lower part of
the scale and overestimation of global disability in the
upper part (Figure 4), residual dependency among items
from the physical and mental domains of disability
(Figure 2), and equal weighing of items (Figure 3). In
comparison, the IRT summed score derived from the
PSS-11 was shown to be a superior summary measure of
patient-assessed global disability in MS with construct
validity greater than that of the PSS-11 and similar to
that of the harder-to-calculate IRT pattern score.
In this study, we developed a table (Additional file 3)
to easily obtain a patient’s IRT summed score of global
disability from their raw PSS-11 score. We showed that
this IRT estimate has a reliability of measurement (0.87)
that is appropriate for both comparisons between groups
and individual-level monitoring. To facilitate intuitive in-
terpretation of where a patient stands relative to the dis-
tribution of scores in the NARCOMS reference sample,
we transformed raw IRT scores into scaled scores with
mean 50 and SD 15 in this sample. Finally, we created a
diagram that provides graphical information about how
each PS contributes to respondents’ perception of their
level of overall disability (Figure 3).
We encountered several challenges in data analysis
which directed us toward solutions that were less than
perfect from a pure measurement perspective. Some ex-
perts stress the importance of focusing efforts on well-
defined, narrow and strictly unidimensional constructs
in order to meet Rasch requirements for fundamental
measurement [31,32]. These experts would probablypoint out that the current PS do not fully cover the
breadth of the dimensions of physical disability and, es-
pecially, mental disability─they would likely recommend
to write and test new PS in order to create two clearly-
distinct, and better-defined, unidimensional measures of
physical and mental disability. Instead, we adopted the
position of those experts who emphasize clinical appro-
priateness at the cost of small measurement bias [33-36]:
i.e., we relied on what the bifactor model enables and
gave priority to incorporating in a single summary meas-
ure the domains of disability most commonly affected by
MS. Analyses suggested that two underlying dimensions
of disability could be identified in the data, but that
these dimensions were ill-defined and highly correlated.
Little reliable information on what we loosely called
“physical” and “mental” disability was left in the PS after
having extracted information on global disability (this in-
formation was provided by the minority of patients af-
fected to markedly different degrees by physical and
mental disability). Scores of residual physical disability
and residual mental disability were significantly associ-
ated with the same patient characteristics. Furthermore,
for both scores of residual disability the patterns of asso-
ciations with patient characteristics was similar to that
observed for scores of global disability. With one excep-
tion, only the strength of some associations differed
slightly depending on the disability score examined. This
exception pertained to high PDDS scores, which were
positively correlated with high scores of global disability
and high scores of residual physical disability, but not
with high scores of mental disability. This finding is
likely, at least in part to be a reflection of the bias of the
upper portion of the PDDS scale toward mobility dis-
ability and physical disability in general.
Table 2 Associations between IRT-derived disability scores and prevalence of unemployment after adjustment for
patient characteristics
Characteristic Bifactor model Unidimensional model
N (%) PRa (95% CI) PRa (95% CI) PRa (95% CI)
Global disability (scaled score, S)b
S ≤ 33.3 562 (14.3) 1.0c,d 1.0c,d 1.0c,e
33.3 < S ≤ 50 1390 (35.4) 1.50 (1.28, 1.77) 1.83 (1.55, 2.17) 1.73 (1.46, 2.04)
50 < S ≤ 66.7 1428 (36.4) 2.14 (1.83, 2.51) 2.75 (2.34, 3.23) 2.87 (2.46, 3.36)
S > 66.7 546 (13.9) 2.74 (2.33, 3.22) 3.66 (3.12, 4.30) 3.79 (3.24, 4.43)
Residual physical disability (scaled score, S)b
S ≤ 33.3 257 (6.5) 1.0c,d
33.3 < S ≤ 50 1876 (47.8) 1.17 (.99, 1.38)
50 < S ≤ 66.7 1339 (34.1) 1.56 (1.32, 1.84)
S > 66.7 454 (11.6) 2.02 (1.70, 2.40)
Residual mental disability (scaled score, S)b
S ≤ 33.3 236 (6.0) 1.0c,d
33.3 < S ≤ 50 1678 (42.7) 1.11 (.98, 1.26)
50 < S ≤ 66.7 1783 (45.5) 1.35 (1.19, 1.52)
S > 66.7 229 (5.8) 1.53 (1.32, 1.78)
Disease duration (y.)
≤ 10 1713 (43.6) 1.0c 1.0c 1.0c
11 – 20 1109 (28.3) 1.06 (.98, 1.14) 1.10 (1.02, 1.19) 1.09 (1.01, 1.18)
≥ 21 1104 (28.1) 1.21 (1.13, 1.30) 1.27 (1.18, 1.37) 1.25 (1.16, 1.34)
Age at assessment (y.)
≤ 35 749 (19.1) 1.0c 1.0c 1.0c
36 – 55 1760 (44.8) 1.01 (.91, 1.11) 1.03 (.93, 1.14) 1.02 (.92, 1.13)
≥ 56 1417 (36.1) 1.22 (1.10, 1.35) 1.31 (1.18, 1.45) 1.28 (1.16, 1.42)
Gender
Female 3102 (79.4) 1.0c 1.0c 1.0c
Male 803 (20.6) 1.04 (.98, 1.10) 1.08 (1.02, 1.15) 1.08 (1.01, 1.14)
Race/Ethnicity
White 3491 (90.2) 1.0c 1.0c 1.0c
African American 132 (3.4) 1.14 (.99, 1.31) 1.16 (1.00, 1.33) 1.14 (.99, 1.31)
Hispanic/Latino 120 (3.1) 1.14 (.97, 1.34) 1.11 (.95, 1.31) 1.12 (.94, 1.31)
Native American 76 (2.0) 1.11 (.95, 1.30) 1.10 (.95, 1.28) 1.09 (.94, 1.25)
Other 49 (1.3) 1.23 (1.00, 1.52) 1.24 (1.00, 1.52) 1.16 (.94, 1.43)
Disease modifying therapy
Yes 2614 (66.6) 1.0c 1.0c 1.0c
No 1312 (33.4) 1.05 (.99, 1.11) 1.08 (1.02, 1.14) 1.06 (1.01, 1.13)
Year of assessment
2003-2005 1640 (41.8) 1.0c 1.0c 1.0c
2006-2008 957 (24.4) 1.01 (.94, 1.08) 1.01 (.94, 1.09) 1.02 (.95, 1.09)
2009-2011 1329 (33.8) 1.04 (.98, 1.11) 1.01 (.94, 1.07) 1.01 (.95, 1.08)
aPR stands for “prevalence ratio”. Because prevalence of unemployment was high, we performed Poisson regression with robust variance estimation instead of
logistic regression to obtain unbiased prevalence ratio estimates [30].
bIRT scores scaled to have mean 50 and SD 15 in the NARCOMS sample.
cReference category.
dBayesian Expected a posteriori (EAP) estimates of disability (i.e., “IRT pattern scores”).
eEAP summed-score estimates of disability (i.e., “IRT summed scores”).
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minous amount of self-assessed disability data collected
during the past decade. For majority of respondents only
the 8 original PS are available. One appealing property of
IRT is that it will theoretically be possible to use our final
IRT model to generate comparable summed and pattern
scores of global disability from different subsets of the 11
PS, including the 8 original PS [37]. Future work will be
needed to establish how reliable these scores are [35].
Equally important will be the need to determine the longi-
tudinal validity of the IRT scales. Because the IRT frame-
work allows one to model the effects of multiple sources
of bias, it will be essential to conduct validation studies
not only with IRT score estimates and conventional statis-
tical methods, but also using latent variable methods such
as multidimensional IRT modeling and IRT modeling for
longitudinal data.Conclusion
In summary, our work suggests that ‘global disability’
due to MS is a statistically validated construct that may
be readily assessed with the simple and quick-to-
administer patient-rated PS. Although, this work was
concerned with methodological issues involved in deriv-
ing such a score of global disability, it has implications
for our understanding of the disease. We showed that
self-assessed disability in MS can be conceptualized as a
multifaceted construct encompassing elements of both
physical and mental disability. Although all the elements
considered were closely correlated, the balance between
them varied among patients with identical global disability
score. This result, derived based on statistical grounds,
challenges the traditional view implicit in accepted disabil-
ity scales (e.g. EDSS), that ‘physical’ disability is of primary
import in MS.Additional files
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